The results of our previous study on the potential of Mpg as a tuberculosis vaccine18 indicated that a temperature-sensitive Mpg, which cannot grow at the core body temperature, was safer in an in vivo challenge as a live vaccine than rBCG, providing a rationale for the development of safe live vaccine using rMpg-p24. This evidence concerns the gene MPG and tuberculosis.